Mid
S
SMMTAI Stock Diagnostic Report
Summit outlines November 14 FDA PDUFA date for ivonescimab BLA while planning HARMONi-3 PFS in 2H 2026
[OR] Summit Therapeutics가 ivonescimab의 FDA PDUFA 날짜를 11월 14일로 발표하며 임상 계획을 구체화했습니다.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time